We intend to develop MeconCash into a platform that allows user’s assets to be transferred and traded between different types of services by integrating point reward systems, contents purchase, and settlement, which are currently operated separately between existing services and those under development. To that end, we will build the reward and settlement system, develop the API to connect it with other services, and build an ecosystem that can be used in the on- and off-line real economy. All this will ensure the usability, connectivity, and sustainability of MeconCash. We will develop a variety of mobile-based applications, games, and contents on the platform and link it with such services as online marketplaces where users can purchase products. The reward system used by a service generally invalidates the rewards owned by users when the service is terminated. MeconCash, however, can transform the rewards obtained from using our services into valuable assets. As such, users will be able to fulfill the demand for new services with MeconCash even when the services they use are terminated, make transactions between them, and use the assets in the real economy. We will stabilize the MeconCash ecosystem by developing new blockchain-based businesses and linking it with external services which already exists. Additionally, MeconCash will be available in 70% of ATMs in Korea so that users can directly withdraw MeconCash to fiat money.

The Constellation protocol implements a horizontally scalable blockchain architecture known as Extended Trust Chain with a peer to peer layer known as a gossip protocol that can be deployed on a mobile device. Constellation approaches smart contracts with a microservice architecture allowing for highly available services to be chained and composed into distributed applications with just an understanding of each microservice’s SLA (service level agreement) and/or type signature. This architecture ensures high transaction throughput, allowing for consumer grade distributed applications to be built on Constellation.

In blockchain world, there is a huge knowledge gulf between non-computer professionals from different industries and smart contract development. The DINO Platform aims to address this problem with its proprietary technology, a cloud-based Graphical User Interface (GUI) smart contract Integrated Development Environment (IDE). Leveraging the technology of the DINO Platform, users can build their smart contracts with visualised logic flows. More than just a smart contract IDE, the DINO Platform is intended to build a smart contract ecosystem together with developers all over the world. In the smart contract market, developers may build and design smart contract templates and sell them to the general public.

AITrading is a revolutionary trading ecosystem, which simplifies experience both for experienced traders as well as for newcomers. It gives tens millions traders the ability to live normal life while AI works for them. AITrading combines AI and Blockchain technologies with trading community capabilities on a single platform.

ELONCITY decentralizes our power infrastructure into millions of self sufficient microgrids. Locally produced energy is available 24/7 and directly competitive to utilities. Energy price becomes transparent to all. People use Eloncity's open technologies to make electricity virtually free so that we can electrify the world with clean energy.

Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.